4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-012596
President sold 30,000 shares at an average $61.49 ($1,844,636)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-17 | Option exercise | +15,000 | $6.55 | $98,250 | 15,000 | D: show line 1 in the form |
| RUBINSTEIN JULIE President | 2021-02-17 | Sale | −5,201 | $61.63 | $320,538 | 9,799 | D: show line 2 in the form |
| RUBINSTEIN JULIE President | 2021-02-17 | Sale | −9,799 | $62.28 | $610,282 | 0 | D: show line 3 in the form |
| RUBINSTEIN JULIE President | 2021-02-18 | Option exercise | +15,000 | $6.55 | $98,250 | 15,000 | D: show line 4 in the form |
| RUBINSTEIN JULIE President | 2021-02-18 | Sale | −5,892 | $60.49 | $356,407 | 9,108 | D: show line 5 in the form |
| RUBINSTEIN JULIE President | 2021-02-18 | Sale | −9,108 | $61.20 | $557,410 | 0 | D: show line 6 in the form |
| Open-market sales · 30,000 sh · avg $61.49 · $1,844,636 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-17 | Option exercise · Stock Option (Right to Buy) | −15,000 | 315,000 | D: show line 7 in the form | |||||
| RUBINSTEIN JULIE President | 2021-02-18 | Option exercise · Stock Option (Right to Buy) | −15,000 | 300,000 | D: show line 8 in the form |
Loading xslF345X03/doc4.xml…